Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024 at 2:15 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor ContactJonathan Neelyjonathan.neely@optinose.com267.521.0531

Grafico Azioni OptiNose (NASDAQ:OPTN)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di OptiNose
Grafico Azioni OptiNose (NASDAQ:OPTN)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di OptiNose